KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Receivables (2016 - 2025)

Historic Receivables for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $391.1 million.

  • Astrana Health's Receivables rose 19327.74% to $391.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.1 million, marking a year-over-year increase of 19327.74%. This contributed to the annual value of $305.5 million for FY2024, which is 29107.21% up from last year.
  • Astrana Health's Receivables amounted to $391.1 million in Q3 2025, which was up 19327.74% from $357.4 million recorded in Q2 2025.
  • Astrana Health's 5-year Receivables high stood at $391.1 million for Q3 2025, and its period low was $67.0 million during Q4 2022.
  • Over the past 5 years, Astrana Health's median Receivables value was $101.2 million (recorded in 2022), while the average stood at $146.4 million.
  • Data for Astrana Health's Receivables shows a peak YoY increase of 29107.21% (in 2024) and a maximum YoY decrease of 1921.57% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Astrana Health's Receivables stood at $80.0 million in 2021, then dropped by 16.26% to $67.0 million in 2022, then grew by 16.62% to $78.1 million in 2023, then skyrocketed by 291.07% to $305.5 million in 2024, then grew by 28.03% to $391.1 million in 2025.
  • Its Receivables was $391.1 million in Q3 2025, compared to $357.4 million in Q2 2025 and $256.0 million in Q1 2025.